Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

64.6K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.6K
What is Gene Expression?01:42

What is Gene Expression?

197.1K
Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
197.1K
What is Gene Expression?01:36

What is Gene Expression?

11.6K
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
11.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

16.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

24.9K
Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare resource utilization and associated costs in patients with metastatic castration-resistant prostate cancer in Greece.

Expert review of pharmacoeconomics & outcomes research·2025
Same author

Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study.

Clinical genitourinary cancer·2024
Same author

The amino acid profile of Camelina sativa seeds correlates with the strongest immune response in dairy ewes.

Animal : an international journal of animal bioscience·2022
Same author

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.

ESMO open·2022
Same author

Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery.

Scientific reports·2021
Same author

Evaluation of nitrogen excretion equations for ryegrass pasture-fed dairy cows.

Animal : an international journal of animal bioscience·2021

Related Experiment Video

Updated: Feb 14, 2026

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

3.5K

Intrathecal gene therapy in mouse models expressing CMT1X mutations.

A Kagiava1, C Karaiskos1, J Richter2

  • 1Neuroscience Laboratory, The Cyprus Institute of Neurology and Genetics, Cyprus School of Molecular Medicine, 1683 Nicosia, Cyprus.

Human Molecular Genetics
|February 21, 2018
PubMed
Summary

Gene therapy shows promise for Charcot-Marie-Tooth disease type 1X (CMT1X) caused by gap junction beta-1 (GJB1) mutations. However, some GJB1 mutants interfere with treatment effectiveness, requiring further research for targeted therapies.

More Related Videos

Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains
04:33

Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains

Published on: March 8, 2024

5.9K
Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

16.0K

Related Experiment Videos

Last Updated: Feb 14, 2026

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

3.5K
Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains
04:33

Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains

Published on: March 8, 2024

5.9K
Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells
10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

16.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • X-linked Charcot-Marie-Tooth disease (CMT1X) is caused by mutations in the gap junction beta-1 (GJB1) gene, affecting connexin32 (Cx32) protein.
  • Previous studies demonstrated therapeutic potential of lentiviral vector-mediated GJB1 gene addition in a Cx32 knockout mouse model.

Purpose of the Study:

  • To evaluate the efficacy of GJB1 gene addition therapy in mouse models of CMT1X harboring specific Cx32 mutations (T55I, R75W, N175D).
  • To investigate whether these CMT1X mutations interfere with the therapeutic expression of wild-type Cx32.

Main Methods:

  • Intrathecal delivery of lentiviral vectors carrying the GJB1 gene into Cx32 knockout mice expressing CMT1X-associated Cx32 mutants.
  • Assessment of Cx32 localization, myelin integrity, motor function, and inflammatory cell infiltration.

Main Results:

  • Virally delivered wild-type Cx32 successfully localized in non-compact myelin of T55I mutant mice, leading to improved motor performance and reduced demyelination and inflammation.
  • The R75W and N175D mutants exhibited dominant-negative effects, hindering wild-type Cx32 expression and resulting in limited or no therapeutic benefit.
  • Mutant Cx32 proteins were retained in the endoplasmic reticulum or Golgi apparatus, indicating impaired trafficking.

Conclusions:

  • GJB1 gene addition therapy is effective for CMT1X caused by non-interfering mutations like T55I.
  • Interfering mutations (R75W, N175D) pose a challenge to gene addition therapy, necessitating the development of alternative therapeutic strategies for these patients.